S. 30 (110th): HOPE Act

Mar 29, 2007 (110th Congress, 2007–2009)
Died (Passed Senate)
Norm Coleman
Senator from Minnesota
Read Text »
Last Updated
Apr 11, 2007
7 pages

This bill was introduced in a previous session of Congress and was passed by the Senate on April 11, 2007 but was never passed by the House.

Introduced Mar 29, 2007
Passed Senate Apr 11, 2007
Full Title

A bill to intensify research to derive human pluripotent stem cell lines.


No summaries available.

Apr 11, 2007 6:20 p.m.
Bill Passed 70/28

6 cosponsors (6R) (show)

House Energy and Commerce

The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


S. stands for Senate bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

4/11/2007--Passed Senate without amendment.
Hope Offered through Principled and Ethical Stem Cell Research Act or the HOPE Act -
Section 3 -
Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not they have an embryonic source), that may result in improved understanding of or treatments for diseases and other adverse health conditions, provided that such techniques do not involve:
(1) the creation of a human embryo or embryos for research purposes; or
(2) the destruction or discarding of, or risk of injury to, a human embryo of embryos other than those that are naturally dead.
Requires the Secretary to:
(1) provide guidance concerning the next steps required for additional research;
(2) prioritize research with the greatest potential for near-term clinical benefits;
(3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research; and
(4) require assurances from grant applicants, in the case of research involving stem cells from a naturally dead embryo, that no alteration of the timing, methods, or procedures used to create, maintain, or intervene in the development of a human embryo was made solely for the purpose of deriving the stem cells.
Sets forth reporting requirements.
Authorizes appropriations.
Section 4 -
Directs the Secretary to enter into a contract with the Institute of Medicine to conduct a study to: (1) recommend an optimal structure for an amniotic and placental stem cell bank program; and (2) address pertinent issues to maximize the potential of such technology.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of S. 30 (110th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus